Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

Victoria Cancer Care Center, Parkville

The Alfred Hospital, Melbourne

Box Hill Hospital, Monash University and Eastern Health Clinical School, Box Hill

Royal Adelaide Hospital, Adelaide

Sir Charles Gairdner Hospital, Nedlands

Hospital Clinic de Barcelona, Barcelona

Institut Català d'Oncologia-Hospital Duran i Reynals, Barcelona

Columbia University Medical Center, New York

Cornell University Weill Medical College, New York

New York Medical College, Hawthorne

Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital Nord, Marseille

Seoul National University Bundang Hospital, Gumi

Roswell Park Cancer Institute, Buffalo

University of Maryland Greenebaum Cancer Center, Baltimore

Duke University Medical Center, Durham

Hospital Universitario 12 De Octubre, Madrid

Emory Winship Cancer Institute, Atlanta

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

University of Miami, Miami

Centre Hospitalier Universitaire (CHU) Bordeaux - Hospitaux du Haut Leveque, Pessac

University Hospital of Rennes, Rennes

Hospital Clínico Universitario de Salamanca, Salamanca

Sarah Cannon Research Institute - Tennessee Oncology, Nashville

Vanderbilt University Medical Center, Nashville

The Ohio State University, Columbus

Centre Hospitalier Universitaire Nantes, Nantes

Hospital La Fe, Valencia

Karmanos Cancer Institute, Detroit

Centre Hospitalier Universitaire de Nancy - Hopital Brabois, Vandœuvre-lès-Nancy

Northwestern University Feinberg School of Medicine, Chicago

Centre Hospitalier Lyon Sud, Pierre-Bénite

Hôpital Saint-Louis, Paris

Hopitaux Universitaires Est Parisien Hopital Saint-Antoine, Paris

University of Texas Southwestern Medical Center, Dallas

MD Anderson Cancer Center, Houston

UCLA Medical Center, Los Angeles

Service d'Hématologie Clinique, Hôpital Avicenne-APHP-Université Paris, Bobigny

Institut de Cancérologie Gustave Roussy, Villejuif

UC Davis Comprehensive Cancer Center, Sacramento

Oregon Health & Science University, Portland

Yale University, New Haven

Princess Margaret Hospital, Toronto

Staedtisches Klinikum Braunschweig gGmbH, Braunschweig

Universitaetsklinikum Giessen und Marburg GmbH - Klinik fuer Innere Medizin, Giessen

Landeszentrum fuer Zell- und Gentherapie, Halle

Universitätsklinikum Münster Medizinische Klinik A, Hämatologie, Hämostaseologi, Münster

AOU S. Luigi Gonzaga - Orbassano, Orbassano

Ospedale Mazzoni - UOC Ematologia Ascoli Piceno, Ascoli Piceno

Universita di Bologna, Bologna

Dipartimento di Oncologia Medica - IRST IRCC, Meldola

Università degli Studi di Parma, Parma

U.O. Ematologia Ravenna, Ravenna

Hospital Rimini Hematology, Department of Oncology and Hematoloy, Rimini

St. George's University Hospital, London

Churchill Hospital, Oxford

Southampton General Hospital, Southampton

Seoul National University Hospital, Seoul

Hospital Vall d'Hebron, Barcelona

University College London Hospitals NHS Foundation Trust, London

Royal Marsden Hospital, Sutton